NCODA is proud to announce our first episode in a series of legislative discussions with thought leaders in the legislative and advocacy space. On this episode, Kevin Scorsone, NCODA Legislative & Policy Liaison interviews Stephen Schleicher, MD and the Chief Medical Officer from Tennessee Oncology and a member of the NCODA Legislative & Policy Advisory Committee.
Stephen Schleicher, MD, MBA, was appointed Chief Medical Officer (CMO) of Tennessee Oncology, one of the largest providers of oncology care, in January 2022. In that role, Dr. Schleicher oversees clinical programs to promote the high-quality, innovative and patient-centered care Tennessee Oncology is known for delivering throughout Tennessee and North Georgia. Dr. Schleicher, who joined Tennessee Oncology four years ago, has already served as Medical Director of Value-Based Care across both Tennessee Oncology and OneOncology, a national platform for independent community oncology practices that now includes over 700 oncology providers across the US. Dr. Schleicher received his medical training from Harvard's Brigham and Women's Hospital and Memorial Sloan Kettering (MSK) in New York before returning to his hometown of Nashville to join Tennessee Oncology. Dr. Schleicher also spent time as a consultant at McKinsey and Company before completing oncology fellowship training at MSK where he focused on understanding the intersection of Accountable Care Organizations and Cancer Care. In addition to his role as CMO for Tennessee Oncology, Dr. Schleicher serves as President of the Tennessee Oncology Practice Society.